Namibia vs Tuvalu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Namibia
1.1%
in 2024
Tuvalu
1.1%
in 2024
Namibia rank
26th
Tuvalu rank
26th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Namibia
- Tuvalu
How they compare
Namibia currently reports 1.1% against 1.1% in Tuvalu, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Namibia ahead.
Namibia ranks 26th and Tuvalu ranks 26th of 215 countries.
Namibia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Namibia | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.3% | 0.1% | Namibia |
| 2020s | 1.2% | 1.2% | 0.0% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Namibia or Tuvalu?
- Namibia, at 1.1% against 1.1% in Tuvalu as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Namibia and Tuvalu?
- 0.0%, with Namibia ahead.
- How many years of comparable data are there for Namibia and Tuvalu?
- 10 years are reported by both, from 2015 to 2024.
- How do Namibia and Tuvalu rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Namibia ranks 26th and Tuvalu ranks 26th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.